Alnylam Pharmaceuticals Stock Forecast
Red day on Thursday for Alnylam Pharmaceuticals
(Updated on Apr 25, 2024)
The Alnylam Pharmaceuticals stock price fell by -0.0626% on the last day (Thursday, 25th Apr 2024) from $143.80 to $143.71. During the last trading day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77. The price has fallen in 8 of the last 10 days and is down by -5.51% for this period. Volume has increased on the last day by 109 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 477 thousand shares were bought and sold for approximately $68.53 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.16% during the next 3 months and, with a 90% probability hold a price between $107.44 and $127.61 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ALNY Signals & Forecast
There are few to no technical positive signals at the moment. The Alnylam Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $144.89 and $149.15. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 08, 2024, and so far it has fallen -7.90%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Alnylam Pharmaceuticals stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.80 between high and low, or 2.67%. For the last week, the stock has had daily average volatility of 2.78%.
Alnylam Pharmaceuticals is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ALNY) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Alnylam Pharmaceuticals to open at $143.82, and during the day (based on 14 day Average True Range), to move between $139.81 and $147.61, which gives a possible trading interval of +/-$3.90 (+/-2.71%) up or down from last closing price. If Alnylam Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.42% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $147.00, some $3.29 (2.29%) from the current price of $143.71, our system finds the risk reward not very attractive.
Earnings coming up
Alnylam Pharmaceuticals will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.750. We will update the financials statements for Alnylam Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.73% in the first trading day after earnings release.
Is Alnylam Pharmaceuticals stock A Buy?
Alnylam Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.311 Sell Candidate Unchanged
Predicted Opening Price for Alnylam Pharmaceuticals of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $143.82 ( 0.0754%) | $143.71 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ALNY
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 147.61 | 2.72 % | |
| R2 | 146.16 | 1.71 % | ||
| R1 | 145.27 | 1.08 % | ||
| Current price: | 143.71 | |||
| Support | S1 | 142.37 | -0.93 % | |
| S2 | 141.47 | -1.56 % | ||
| S3 | 140.02 | -2.57 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 154.74 | 7.68 % | |
| R2 | 147.43 | 2.59 % | ||
| R1 | 147.00 | 2.29 % | ||
| Current price | 143.71 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Alnylam Pharmaceuticals Stock.
